MedTrace Logo

Spinal Cord Stimulation for the Treatment of Major Depressive Disorder

NCT03433339 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-12-27

Study results available
· View outcomes & findings →

Summary

This pilot clinical trial will evaluate the efficacy and safety of transcutaneous direct current stimulation (tsDCS) in major depressive disorder.

Conditions

Interventions

DEVICE

Active transcutaneous spinal direct current stimulation

Active anode electrodes placed at Thoracic 10 level, Cathode electrode placed on right shoulder.

DEVICE

Sham transcutaneous spinal direct current stimulation

Sham anode electrodes placed at Thoracic 10 level, Cathode electrode placed on right shoulder.

Sponsors & Collaborators

  • Lindner Center of HOPE

    collaborator OTHER

  • Brain & Behavior Research Foundation

    collaborator OTHER

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Francisco Romo-Nava, MD,PhD · University of Cincinnati/ Lindner Center of HOPE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-29
Primary Completion
2022-09-13
Completion
2022-09-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03433339 on ClinicalTrials.gov